Dr. Martens (LON:DOCS) Stock Price Down 13.7% – What’s Next?

Dr. Martens plc (LON:DOCS) was down 13.7% during mid-day trading on Tuesday . The company traded as low as GBX 65 and last traded at GBX 65.29. Approximately 3,337,086 shares were traded during mid-day trading, an increase of 93% from the average daily volume of 1,727,242 shares. The stock had previously closed at GBX 75.65.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on DOCS shares. Peel Hunt reiterated a “buy” rating on shares of Dr. Martens in a research note on Thursday, November 20th. Berenberg Bank reiterated a “buy” rating on shares of Dr. Martens in a research report on Tuesday. Two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, Dr. Martens presently has a consensus rating of “Moderate Buy” and an average target price of GBX 6,000.

Dr. Martens Stock Up 4.0%

The business has a 50-day moving average of GBX 75.88 and a 200 day moving average of GBX 83.26. The company has a market capitalization of £660.64 million, a PE ratio of 40.21, a P/E/G ratio of 6.40 and a beta of 0.11. The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13.

Dr. Martens (LON:DOCS) last posted its earnings results on Thursday, November 20th. The company reported GBX (0.90) EPS for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. Equities research analysts predict that Dr. Martens plc will post 2.5809394 earnings per share for the current year.

Insider Buying and Selling at Dr. Martens

In other Dr. Martens news, insider Robert Hanson bought 96,000 shares of the firm’s stock in a transaction dated Friday, December 5th. The shares were purchased at an average cost of GBX 79 per share, for a total transaction of £75,840. In the last 90 days, insiders have bought 97,130 shares of company stock valued at $7,673,816. Insiders own 2.79% of the company’s stock.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over
60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and
wholesale channels, and in addition to its world-renowned “1460” boot its product segments span shoes including the
1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and
accessories.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.